Copper homeostasis: Emerging target for cancer treatment
- PMID: 32599675
- DOI: 10.1002/iub.2341
Copper homeostasis: Emerging target for cancer treatment
Abstract
Copper (Cu) is an essential micronutrient involved in a variety of fundamental biological processes. Recently, disorder of Cu homeostasis can be observed in many malignancies. Elevated Cu levels in serum and tissue are correlated with cancer progression. Hence, targeting Cu has emerged as a novel strategy in cancer treatment. This review provides an overview of physiological Cu metabolism and its homeostasis, followed by a discussion of the dysregulation of Cu homeostasis in cancer and the effects of Cu on cancer progression. Finally, recent therapeutic advances using Cu coordination complexes as anticancer agents, as well as the mechanisms of their anti-cancer action are discussed. This review contributes full comprehension to the role of Cu in cancer and demonstrates the broad application prospect of Cu coordination compounds as potential therapeutic agents.
Keywords: cancer treatment; copper chelators; copper homeostasis; copper ionophores.
© 2020 International Union of Biochemistry and Molecular Biology.
References
REFERENCES
-
- Gaetke LM, Chow-Johnson HS, Chow CK. Copper: Toxicological relevance and mechanisms. Arch Toxicol. 2014;88(11):1929-1938.
-
- Balsano C, Porcu C, Sideri S. Is copper a new target to counteract the progression of chronic diseases? Metallomics. 2018;10(12):1712-1722.
-
- Garber K. Cancer's copper connections. Science. 2015;349(6244):129.
-
- Lopez J, Ramchandani D, Vahdat L. Copper depletion as a therapeutic strategy in cancer. Metal Ions Life Sci. 2019;19:303-330.
-
- Blockhuys S, Celauro E, Hildesjo C, Feizi A, Stal O, et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics. 2017;9(2):112-123.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
